Signup/Login
If you want to receive notifications of upcoming IPOs, you need to simply sign up or sign in with social networks.
Signup/Login
Can you determine which companies are good and which ones - the trash?
Free Pro-version
IPO Filter
Monitor
IPO today
Breeze Holdings Acquisition (BREZU)
Upcoming IPO
AMMO (POWW)
Vision Marine Technologies (VMAR)
Spring Valley Acquisition (SVSVU)
Genesis Park Acquisition (GNPK.U)
Ozon Holdings Plc (OZON)
Tiga Acquisition (TINVU)
Spartan Acquisition Corp. II (SPRQ.U)
Priced IPO
Sotera Health Company (SHC)
Maravai LifeSciences Holdings, Inc. (MRVI)
Telos Corporation (TLS)
NeoGames S.A (NGMS)
Olema Pharmaceuticals, Inc. (OLMA)
Yatsen Holding Limited (YSG)
Lufax Holding Ltd (LU)
Atea Pharmaceuticals, Inc. (AVIR)
SQZ Biotechnologies Company (SQZ)
Allegro MicroSystems, Inc. (ALGM)
Galecto, Inc. (GLTO)
Leslie's Inc (LESL)
Gatos Silver, Inc. (GATO)
Biodesix, Inc. (BDSX)
MediaAlpha, Inc. (MAX)
Root, Inc. (ROOT)
Absolute Software (ABST)
EQT Corporation (EQT)
Foghorn Therapeutics Inc. (FHTX)
McAfee Corp. (MCFE)
More companies

Biodesix, Inc. (BDSX)

Sector - Healthcare

Price chart

Company News

IPO Profile

About company

They are a leading data-driven diagnostic solutions company leveraging state of the art technologies with their proprietary artificial intelligence (AI) platform to discover, develop, and commercialize solutions for clinical unmet needs, with a primary focus in lung disease. By combining a technology agnostic approach with a holistic view of the patient’s disease state, they believe their solutions provide physicians with greater insights to help personalize their patient’s care and meaningfully improve disease detection, evaluation, and treatment. Their unique approach to precision medicine provides timely and actionable clinical information, which they believe improves overall patient outcomes and lowers the overall healthcare cost by reducing the use of ineffective and unnecessary treatments and procedures. In addition to their diagnostic tests, they provide biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. Their core belief is that no single technology will answer all clinical questions that they encounter. Therefore, they employ multiple technologies, including genomics, transcriptomics, proteomics, and radiomics, and leverage their proprietary AI platform, the Diagnostic Cortex®, to discover innovative diagnostic tests for clinical use.
Industry
Services - Medical Laboratories
CEO CFO
Scott Hutton Robin Harper Cowie
Employees Founded
154 2005

Contacts

Address: 2970 Wilderness Place, Suite 100 Boulder, Colorado 80301

Telephone: (303) 417-0500

Web page: http://www.biodesix.com

IPO information

Expected Date 10/28/2020
Status Priced
Exchange NASDAQ
Lockup Period Expiration .Pro
Quiet Period Expiration .Pro
Old Price Range
-
Share prices ($)

Financial Data (last reporting year)

Market Cap (MM) $475.56
Revenues (MM) $21.6
Net Income (Loss) (MM) $-34.1

Voting

What do you think will happen with the BDSX share price after the next 3-6 months? 🔥 (+ 10% or more, flat (+ -10%), -10% or less)

Number of votes: img
Shares Initial (MM) 4.2
Shares Revised (MM) 4
Expected offer amount (MM) $75.6
Realized offer amount(MM) $72
Underwriters
Morgan Stanley/ William Blair
CO-Managers
Canaccord Genuity/ BTIG

Sector: Healthcare

Tweets about $BDSX

Tweets volume:

RT volume:

Timeframe:

Google Trends Stats